DK0509752T3 - Oftalmiske præparater, der omfatter kombinationer af en carbonathydrolyaseinhibitor og en beta-adrenerg antagonist - Google Patents

Oftalmiske præparater, der omfatter kombinationer af en carbonathydrolyaseinhibitor og en beta-adrenerg antagonist

Info

Publication number
DK0509752T3
DK0509752T3 DK92303330T DK92303330T DK0509752T3 DK 0509752 T3 DK0509752 T3 DK 0509752T3 DK 92303330 T DK92303330 T DK 92303330T DK 92303330 T DK92303330 T DK 92303330T DK 0509752 T3 DK0509752 T3 DK 0509752T3
Authority
DK
Denmark
Prior art keywords
beta
combinations
inhibitor
hydrolyase
carbonate
Prior art date
Application number
DK92303330T
Other languages
Danish (da)
English (en)
Inventor
John J Baldwin
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27103852&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0509752(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Application granted granted Critical
Publication of DK0509752T3 publication Critical patent/DK0509752T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/38Heterocyclic compounds having sulfur as a ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0048Eye, e.g. artificial tears
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • A61P27/06Antiglaucoma agents or miotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Ophthalmology & Optometry (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK92303330T 1991-04-17 1992-04-14 Oftalmiske præparater, der omfatter kombinationer af en carbonathydrolyaseinhibitor og en beta-adrenerg antagonist DK0509752T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US68671891A 1991-04-17 1991-04-17
US83491392A 1992-02-13 1992-02-13

Publications (1)

Publication Number Publication Date
DK0509752T3 true DK0509752T3 (da) 1999-12-06

Family

ID=27103852

Family Applications (1)

Application Number Title Priority Date Filing Date
DK92303330T DK0509752T3 (da) 1991-04-17 1992-04-14 Oftalmiske præparater, der omfatter kombinationer af en carbonathydrolyaseinhibitor og en beta-adrenerg antagonist

Country Status (24)

Country Link
EP (1) EP0509752B1 (fr)
JP (1) JP2527513B2 (fr)
KR (1) KR920019348A (fr)
CN (1) CN1073421C (fr)
AT (1) ATE182787T1 (fr)
AU (1) AU648659C (fr)
CA (1) CA2065965C (fr)
CH (1) CH0509752H1 (fr)
CY (1) CY2146B1 (fr)
CZ (1) CZ285129B6 (fr)
DE (3) DE69229688C5 (fr)
DK (1) DK0509752T3 (fr)
ES (1) ES2133304T3 (fr)
GR (1) GR3031467T3 (fr)
IE (1) IE921240A1 (fr)
IL (1) IL101537A (fr)
LU (1) LU90506I2 (fr)
MX (1) MX9201785A (fr)
NL (1) NL990041I2 (fr)
NO (1) NO306196B1 (fr)
RO (1) RO113612B1 (fr)
SK (1) SK282039B6 (fr)
WO (1) WO1992018124A1 (fr)
YU (1) YU39392A (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5932572A (en) * 1992-02-21 1999-08-03 Alcon Laboratories, Inc. Topical anti-glaucoma compositions
ES2118941T3 (es) * 1992-02-21 1998-10-01 Alcon Lab Inc Composiciones antiglaucoma topicas que comprenden inhibidores de anhidrasa carbonica y bloqueantes beta.
US6071904A (en) * 1996-12-11 2000-06-06 Alcon Laboratories, Inc. Process for manufacturing ophthalmic suspensions
FI981473A7 (fi) * 1998-06-25 1999-12-26 Orion Yhtymae Oyj Menetelmä pulmonaalihypertension hoitamiseksi
TWI298257B (en) 2001-05-31 2008-07-01 Allergan Inc Hypotensive lipid and timolol compositions and methods of using same
CN100345594C (zh) * 2004-01-19 2007-10-31 无锡杰西医药科技有限公司 乙酰唑胺滴眼液
US8211450B2 (en) * 2010-05-05 2012-07-03 Senju Usa, Inc. Ophthalmic composition
US9061034B2 (en) 2010-07-29 2015-06-23 Allergan, Inc. Preservative free bimatoprost and timolol solutions
RU2624534C2 (ru) 2010-07-29 2017-07-04 Аллерган, Инк. Растворы биматопроста и тимолола, не содержащие консервантов
JP5893204B1 (ja) * 2015-02-23 2016-03-23 参天製薬株式会社 防腐効果のある医薬の組合せ
JP6132968B1 (ja) * 2016-01-29 2017-05-24 参天製薬株式会社 ドルゾラミド、高分子およびホウ酸を含有する医薬組成物

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4863922A (en) * 1984-12-12 1989-09-05 Merck & Co., Inc. Substituted aromatic sulfonamides as antiglaucoma agents, compositions and use

Also Published As

Publication number Publication date
IL101537A (en) 1997-11-20
DE10075002I2 (de) 2004-07-01
NO933714D0 (no) 1993-10-15
JPH05117167A (ja) 1993-05-14
CN1073421C (zh) 2001-10-24
WO1992018124A1 (fr) 1992-10-29
IE921240A1 (en) 1992-10-21
CZ285129B6 (cs) 1999-05-12
GR3031467T3 (en) 2000-01-31
DE69229688C5 (de) 2010-10-21
MX9201785A (es) 1992-10-01
HK1009251A1 (en) 1999-05-28
DE69229688T2 (de) 2000-02-24
EP0509752A2 (fr) 1992-10-21
AU648659B2 (en) 1994-04-28
CA2065965A1 (fr) 1992-10-18
NO306196B1 (no) 1999-10-04
IL101537A0 (en) 1992-12-30
AU648659C (en) 2008-02-14
KR920019348A (ko) 1992-11-19
RO113612B1 (ro) 1998-09-30
ATE182787T1 (de) 1999-08-15
SK110393A3 (en) 1994-02-02
NO933714L (no) 1993-10-15
CA2065965C (fr) 1998-06-16
NL990041I1 (nl) 2000-02-01
EP0509752A3 (en) 1993-03-03
CZ209893A3 (en) 1994-06-15
JP2527513B2 (ja) 1996-08-28
DE69229688T4 (de) 2010-08-19
CN1066781A (zh) 1992-12-09
LU90506I2 (fr) 2000-03-28
ES2133304T3 (es) 1999-09-16
YU39392A (sh) 1995-12-04
CY2146B1 (en) 2002-06-21
AU1497992A (en) 1992-10-22
CH0509752H1 (fr) 2012-11-30
EP0509752B1 (fr) 1999-08-04
DE69229688D1 (de) 1999-09-09
SK282039B6 (sk) 2001-10-08
DE10075002I1 (de) 2000-03-30
NL990041I2 (nl) 2000-04-03

Similar Documents

Publication Publication Date Title
EP0594602A4 (fr) Inhibiteurs d'anhydrase carbonique du thiadiazole sulfonamide a activite topique oculaire.
FI921924A7 (fi) Portabel koldioxidmonitor
TR22827A (tr) N-(4-fenoksi-2,6-diizopropilfenil)-n'-ters,butil tio,uerenin beyaz sineklerle muecadelede kullanilmasi
DE19575017I2 (de) Substituierte aromatische Sulfonamide als Mittel gegen Glaukom.
IT8553000U1 (it) Dispositivo di protezione del capo per attivita' sportive, particolarmente per sci agonistico.
DE69418947D1 (de) Stilbenderivate und analoga sowie deren anwendung
ATE133663T1 (de) Antiglancoma-zusammensetzungen enthaltend 3- arylcarbonyl-1-aminoalkyl-1h-indol
DK0721457T3 (da) 2',5'-Oligoadenylat-2',3'-cyclophosphater og 2',5'-oligo-adenylater med antipapillomavirusaktivitet
GR3031467T3 (en) Ophthalmic compositions comprising combinations of a carbonic anhydrase inhibitor and a beta-adrenergic antagonist
DK0679717T3 (da) Opløselig interferon-receptor og fremstilling og anvendelse heraf
DE69329945D1 (de) Polarisierendes element, optisches element und optischer kopf
ITMI911671A1 (it) Testa di avvitatura spezzabile e monouso, a coppia di avvitatura predeterminata.
FI961977A0 (fi) N-substituoidut atsabisykloalkaanijohdannaiset, niiden valmistus ja käyttö
NO991581D0 (no) N-(benzotiazol-2-yl)piperidin-1-etanaminderivater, deres fremstilling og anvendelse i terapeutiske midler
DK0458587T3 (da) Behandling af okulær hypertension med en synergistisk kombination til ophthalmisk anvendelse
DK223287A (da) Heterocycliske sulfonamider og deres anvendelse som herbicider
FI970165L (fi) (S)-atenosyyli-L-metioniinin (SAMe) ja sen fysiologisesti hyväksyttävien suolojen käyttö tilapäisen fokaalisen iskemian aiheuttamien reperfuusiovammojen hoitamiseksi
DK435089A (da) Anvendelse af zofenopril til behandling af rheumatoid arthritis
KR930011853U (ko) 전기 광학 주사 장치와, 주사 장치에 사용하기 위한 힌지 요소, 및 주사 장치를 포함한 광학 플레이어
NO942322D0 (no) Nye 3-halogen-5-halogenmetyl-2-oksazolidinoner og deres anvendelse som mikrobicider
NO914779L (no) Adenosin-forbindelse i ny krystallform, fremgangsmaate fordens fremstilling og terapeutisk anvendelse derav
ITMI910913U1 (it) Portaombrelli portatile, in particolare per l'utilizzo all'interno di autovetture
KR940021123U (ko) 두 편광자의 교차를 이용한 작업용 보안경
NO871946D0 (no) Solskjerm i ny konstruksjon med alternative bruksomraader.
DK617689D0 (da) (d)-6-fluor-2,3-dihydro-2',5'-dioxo-spirooe4h-1-benzopyran-4,4'-imidazolidinaa-2-carboxamidderivater, fremgangsmaade til deres fremstilling og deres anvendelse